Urinary Tract Infection Prophylaxis in Children with Neurogenic Bladder with Cranberry Capsules: Randomized Controlled Trial

Table 2

Infection rates of patients during placebo and cranberry usage.

	Infection rate of group during placebo/year	Infection rate of group during cranberry/year	𝑃
Whole group	0.70 ± 0.92; (0.5)	0.45 ± 0.82; (0)	0.012^∗
Girls	1.07 ± 1.18; (1)	0.30 ± 0.63; (0)	0.008^∗
Boys	0.42 ± 0.53; (0)	0.28 ± 0.48; (0)	0.655
Patients with VUR	0.5 ± 0.57; (0.5)	0.0 ± 0.0; (0.5)	0.157
Patients without VUR	0.93 ± 1.12; (0.5)	0.37 ± 0.61; (0)	0.029^*
Patients with renal scar	0.84 ± 1.06; (1)	0.23 ± 0.43; (0)	0.033^*
Patients without renal scar	0.85 ± 1.06; (0)	0.42 ± 0.78; (0)	0.180